| Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine SG Hansen, JC Ford, MS Lewis, AB Ventura, CM Hughes, ... Nature 473 (7348), 523-527, 2011 | 1135 | 2011 |
| Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge SG Hansen, C Vieville, N Whizin, L Coyne-Johnson, DC Siess, ... Nature medicine 15 (3), 293-299, 2009 | 773 | 2009 |
| Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge SG Hansen, C Vieville, N Whizin, L Coyne-Johnson, DC Siess, ... Nature medicine 15 (3), 293-299, 2009 | 771 | 2009 |
| Coding potential of laboratory and clinical strains of human cytomegalovirus E Murphy, D Yu, J Grimwood, J Schmutz, M Dickson, MA Jarvis, G Hahn, ... Proceedings of the National Academy of Sciences 100 (25), 14976-14981, 2003 | 667 | 2003 |
| Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells BJ Ryckman, BL Rainish, MC Chase, JA Borton, JA Nelson, MA Jarvis, ... Journal of virology 82 (1), 60-70, 2008 | 460 | 2008 |
| Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion BJ Ryckman, MA Jarvis, DD Drummond, JA Nelson, DC Johnson Journal of virology 80 (2), 710-722, 2006 | 459 | 2006 |
| Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus SG Hansen, CJ Powers, R Richards, AB Ventura, JC Ford, D Siess, ... Science 328 (5974), 102-106, 2010 | 336 | 2010 |
| Human cytomegalovirus persistence and latency in endothelial cells and macrophages MA Jarvis, JA Nelson Current opinion in microbiology 5 (4), 403-407, 2002 | 252 | 2002 |
| Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine SG Hansen, DE Zak, G Xu, JC Ford, EE Marshall, D Malouli, RM Gilbride, ... Nature medicine 24 (2), 130-143, 2018 | 243 | 2018 |
| A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells PT Wille, AJ Knoche, JA Nelson, MA Jarvis, DC Johnson Journal of virology 84 (5), 2585-2596, 2010 | 209 | 2010 |
| Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection K Rosenke, K Meade-White, M Letko, C Clancy, F Hansen, Y Liu, ... Emerging microbes & infections 9 (1), 2673-2684, 2020 | 199 | 2020 |
| Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kit Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the … AV Moses, MA Jarvis, C Raggo, YC Bell, R Ruhl, BGM Luukkonen, ... Journal of virology 76 (16), 8383-8399, 2002 | 164 | 2002 |
| Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model K Rosenke, F Hansen, B Schwarz, F Feldmann, E Haddock, R Rosenke, ... Nature communications 12 (1), 2295, 2021 | 158 | 2021 |
| Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal MA Jarvis, JA Nelson Journal of virology 81 (5), 2095-2101, 2007 | 147 | 2007 |
| A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virus Y Tsuda, P Caposio, CJ Parkins, S Botto, I Messaoudi, L Cicin-Sain, ... PLoS neglected tropical diseases 5 (8), e1275, 2011 | 125 | 2011 |
| Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL NR Hegde, C Dunn, DM Lewinsohn, MA Jarvis, JA Nelson, DC Johnson The Journal of experimental medicine 202 (8), 1109-1119, 2005 | 112 | 2005 |
| Human cytomegalovirus attenuates interleukin-1β and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-κB activation MA Jarvis, JA Borton, AM Keech, J Wong, WJ Britt, BE Magun, JA Nelson Journal of virology 80 (11), 5588-5598, 2006 | 102 | 2006 |
| Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious … WJ Britt, M Jarvis, JY Seo, D Drummond, J Nelson Journal of virology 78 (1), 539-543, 2004 | 99 | 2004 |
| A protein-based therapeutic for human cytomegalovirus infection F Jean, L Thomas, SS Molloy, G Liu, MA Jarvis, JA Nelson, G Thomas Proceedings of the National Academy of Sciences 97 (6), 2864-2869, 2000 | 94 | 2000 |
| The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens I Dekhtiarenko, MA Jarvis, Z Ruzsics, L Čičin-Šain The Journal of Immunology 190 (7), 3399-3409, 2013 | 80 | 2013 |
